Equities

Joinn Laboratories China Co Ltd

Joinn Laboratories China Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)9.42
  • Today's Change-0.16 / -1.67%
  • Shares traded475.37k
  • 1 Year change-59.17%
  • Beta--
Data delayed at least 15 minutes, as of Apr 24 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.

  • Revenue in HKD (TTM)2.57bn
  • Net income in HKD429.47m
  • Incorporated1998
  • Employees2.51k
  • Location
    Joinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
  • Phone+86 1 067869582
  • Fax+86 1 067869966
  • Websitehttps://www.joinnlabs.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cansino Biologics Inc373.42m-1.60bn8.46bn1.49k--0.7979--22.65-6.50-6.501.5123.060.03322.370.4626249,945.80-18.93-4.27-26.69-5.60-253.78---569.97-27.721.86--0.3381---66.52213.94-63.04--30.60--
InnoCare Pharma Ltd798.95m-682.90m8.60bn1.07k--0.9622--10.76-0.4049-0.40490.47354.390.0731.393.39---6.38-13.41-8.08-15.3682.6185.99-87.42-172.164.13--0.1582--18.09240.3628.80------
Keymed Biosciences Inc383.06m-388.75m9.04bn897.00--2.77--23.59-1.49-1.491.4511.680.09060.731426.14427,046.90-9.16---10.05--89.59---101.04--9.18--0.123--253.87---16.63------
Luye Pharma Group Ltd6.65bn576.17m9.97bn5.01k17.220.69397.431.500.15390.15391.783.820.2472.423.24--2.172.803.564.4568.4470.538.7810.391.212.680.3837--2.703.50-11.94-16.39----
AIM Vaccine Co Ltd1.28bn-1.41bn10.16bn1.62k--2.58--7.91-1.16-1.161.063.25------791,013.90--------75.88---164.24--0.7583-11.540.3158---6.06---307.07------
Yichang Hec Changjiang Pharmactcl Co Ltd6.81bn2.16bn10.63bn4.62k4.931.244.371.562.452.457.749.760.51113.624.001,474,557.0015.078.0324.4611.8179.2179.9729.4820.801.309.320.2475--68.0820.182,501.2416.15----
SciClone Pharmaceuticals (Holdings) Ltd3.41bn1.21bn11.30bn1.05k9.663.2014.753.311.861.865.255.630.75853.563.833,251,194.0026.9727.0933.3436.3274.6776.0635.5535.434.5027.950.01--14.7617.5031.1615.96----
Zai Lab Ltd2.09bn-2.62bn11.98bn2.18k--1.88--5.73-2.71-2.712.166.420.23642.515.38---29.66-37.72-34.97-42.7264.0864.75-125.46-282.444.41--0.00--24.03360.0324.51---3.45--
Joinn Laboratories China Co Ltd2.57bn429.47m13.08bn2.51k16.730.802122.665.090.57260.57263.4311.940.23311.747.121,024,259.003.848.924.5911.0141.2146.6716.4832.004.73--0.008324.504.7842.20-63.0430.36----
Simcere Pharmaceutical Group Ltd7.15bn773.23m13.62bn7.03k18.001.7612.301.910.29010.29012.742.970.61063.532.651,017,268.006.6010.178.9415.6075.4378.8210.8017.501.870.97290.1652--4.497.92-23.22-0.5213----
SSY Group Ltd6.46bn1.32bn13.92bn5.60k10.592.017.962.150.44270.44272.172.330.56373.003.011,154,109.0011.5910.5115.5814.0356.0158.7220.5718.621.6029.610.31738.560.45059.1017.447.663.9413.56
3SBio Inc8.46bn1.68bn13.98bn5.41k8.480.90536.721.650.67550.67553.466.330.34261.586.751,562,614.006.957.449.039.2984.9882.9120.3021.502.265.260.2266--13.8411.26-19.133.94----
Grand Pharmaceutical Group Ltd10.53bn1.88bn14.16bn10.53k7.450.92186.191.350.53560.53563.004.330.46922.945.06999,581.408.4510.0911.6614.0161.9661.9718.0022.350.981923.210.183126.9510.1212.06-9.5921.41--24.77
The United Laboratories Intl. Hldgs Ltd.14.86bn2.92bn17.04bn15.00k5.831.244.821.151.611.618.187.580.68713.363.26990,922.9013.517.8920.5212.6446.1144.1719.6612.731.74--0.105515.5121.2212.8470.8531.66--14.67
Data as of Apr 24 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.